PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults
Status:
NOT_YET_RECRUITING
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy and safety of PEG-rhGH Injection combined with Semaglutide Injection versus Semaglutide Injection monotherapy in improving body composition (lean body mass, fat mass, etc.) in non-diabetic obese adults, while also analyzing changes in body weight, blood glucose, and other metabolic parameters.
Phase:
PHASE4
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Treatments:
polyethylene glycol-recombinant human growth hormone semaglutide